<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000703577"><TermName>recombinant human papillomavirus bivalent vaccine</TermName><TermPronunciation>(ree-KOM-bih-nunt HYOO-mun PA-pih-LOH-muh-VY-rus by-VAY-lent vak-SEEN)</TermPronunciation><TermDefinition><DefinitionText>A vaccine used
          to prevent cervical cancer caused by human papillomavirus
          (HPV) types 16 and 18. Recombinant human papillomavirus bivalent vaccine
          is approved for use in females aged 9 to 25 years. It is a
          type of bivalent vaccine (a vaccine that works against two
          different viruses or other
          microorganisms). Also called Cervarix.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000732879" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;recombinant human papillomavirus bivalent vaccine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000732880" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;vacuna recombinante bivalente contra el virus del papiloma humano&quot;" language="es" id="_4"/><SpanishTermName>vacuna recombinante bivalente contra el virus del papiloma humano</SpanishTermName><SpanishTermDefinition><DefinitionText>Vacuna que se usa para prevenir
el cáncer de cuello uterino causado por los virus del papiloma
humano (VPH) tipos 16 y 18. La vacuna recombinante bivalente contra el papilomavirus humano está aprovada para su uso en mujeres de 9 a 25 años.   Es un tipo de vacuna bivalente (una vacuna que trabaja contra dos virus diferentes u otros microorganismos). También se llama Cervarix.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2011-07-13</DateFirstPublished><DateLastModified>2014-01-03</DateLastModified><RelatedInformation><RelatedExternalRef UseWith="en" xref="http://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet">Human Papillomavirus (HPV) Vaccines</RelatedExternalRef><RelatedDrugSummaryRef href="CDR0000658573">Recombinant Human Papillomavirus (HPV) Bivalent Vaccine</RelatedDrugSummaryRef><RelatedExternalRef UseWith="es" xref="http://www.cancer.gov/espanol/cancer/causas-prevencion/riesgo/germenes-infecciosos/hoja-informativa-vacuna-vph">Vacunas contra los virus del papiloma humano</RelatedExternalRef></RelatedInformation></GlossaryTerm>
